DK1150703T3 - Behandling af multipel sclerose med chaperonin 10 og beta-interferon - Google Patents

Behandling af multipel sclerose med chaperonin 10 og beta-interferon

Info

Publication number
DK1150703T3
DK1150703T3 DK00903434T DK00903434T DK1150703T3 DK 1150703 T3 DK1150703 T3 DK 1150703T3 DK 00903434 T DK00903434 T DK 00903434T DK 00903434 T DK00903434 T DK 00903434T DK 1150703 T3 DK1150703 T3 DK 1150703T3
Authority
DK
Denmark
Prior art keywords
chaperonin
multiple sclerosis
treatment
beta interferon
beta
Prior art date
Application number
DK00903434T
Other languages
Danish (da)
English (en)
Inventor
Halle Morton
Alice Cavanagh
Original Assignee
Univ Queensland
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Queensland filed Critical Univ Queensland
Application granted granted Critical
Publication of DK1150703T3 publication Critical patent/DK1150703T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/19—Cytokines; Lymphokines; Interferons
    • A61K38/21—Interferons [IFN]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/19—Cytokines; Lymphokines; Interferons
    • A61K38/21—Interferons [IFN]
    • A61K38/215—IFN-beta
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Immunology (AREA)
  • Biomedical Technology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Zoology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Psychiatry (AREA)
  • Hospice & Palliative Care (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
  • Peptides Or Proteins (AREA)
  • Developing Agents For Electrophotography (AREA)
  • Surgical Instruments (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
DK00903434T 1999-01-20 2000-01-20 Behandling af multipel sclerose med chaperonin 10 og beta-interferon DK1150703T3 (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
AUPP8239A AUPP823999A0 (en) 1999-01-20 1999-01-20 A treatment

Publications (1)

Publication Number Publication Date
DK1150703T3 true DK1150703T3 (da) 2006-05-29

Family

ID=3812443

Family Applications (1)

Application Number Title Priority Date Filing Date
DK00903434T DK1150703T3 (da) 1999-01-20 2000-01-20 Behandling af multipel sclerose med chaperonin 10 og beta-interferon

Country Status (12)

Country Link
US (1) US20090214473A1 (https=)
EP (1) EP1150703B1 (https=)
JP (1) JP4691257B2 (https=)
KR (1) KR100694011B1 (https=)
AT (1) ATE313332T1 (https=)
AU (2) AUPP823999A0 (https=)
CA (1) CA2361081C (https=)
DE (1) DE60024967T2 (https=)
DK (1) DK1150703T3 (https=)
ES (1) ES2255484T3 (https=)
PT (1) PT1150703E (https=)
WO (1) WO2000043033A1 (https=)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NZ548985A (en) * 2004-01-16 2010-02-26 Cbio Ltd Chaperonin 10 modulation of toll-like receptor-inducible cytokine and chemokine secretion
BG66458B1 (bg) 2005-03-21 2014-10-31 Иван Иванов Средство за конкурентно инхибиране на ендогенен гама интерферон
EP2457930A1 (en) 2005-08-31 2012-05-30 CBIO Limited Modified chaperonin 10
CN101330922A (zh) * 2005-10-20 2008-12-24 悉生物有限公司 超敏的治疗
CA2644058C (en) * 2006-03-02 2016-08-09 Cbio Limited Regulation of immune responses by modulation of the function of antigen presenting cells
US9359421B2 (en) 2008-04-08 2016-06-07 Tigo Gmbh Suppressor of the endogenous interferon-gamma
BG66517B1 (bg) 2008-04-08 2016-02-29 Tigo Gmbh Супресор на ендогенния човешки гама - интерферон
BG1430U1 (bg) * 2010-06-25 2011-04-29 Иван ИВАНОВ Фармацевтично средство
BG67190B1 (bg) 2017-03-29 2020-11-16 Tigo Gmbh Анти-гама мутантен протеин срещу ендогенния човешки гама интерферон

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1995015339A1 (en) * 1993-11-30 1995-06-08 The University Of Queensland Antagonists to chaperonin 10
JPH10500109A (ja) * 1994-05-10 1998-01-06 イミユロジク・フアーマシユーチカル・コーポレーシヨン 多発性硬化症のための組成物および治療方法
DE19544768C1 (de) * 1995-11-30 1997-07-10 Rentschler Arzneimittel Verwendung einer Kombination aus Pentoxifyllin mit Typ-I-Interferonen zur Behandlung der Multiplen Sklerose

Also Published As

Publication number Publication date
KR20020002376A (ko) 2002-01-09
ATE313332T1 (de) 2006-01-15
AU2527100A (en) 2000-08-07
ES2255484T3 (es) 2006-07-01
CA2361081C (en) 2010-09-21
JP4691257B2 (ja) 2011-06-01
EP1150703B1 (en) 2005-12-21
EP1150703A1 (en) 2001-11-07
JP2002535286A (ja) 2002-10-22
KR100694011B1 (ko) 2007-03-12
CA2361081A1 (en) 2000-07-27
DE60024967D1 (en) 2006-01-26
PT1150703E (pt) 2006-05-31
WO2000043033A1 (en) 2000-07-27
EP1150703A4 (en) 2004-11-10
DE60024967T2 (de) 2006-08-17
US20090214473A1 (en) 2009-08-27
AU771867B2 (en) 2004-04-01
AUPP823999A0 (en) 1999-02-11

Similar Documents

Publication Publication Date Title
DK1025124T3 (da) Human interferon-alfa-analoge med lav toksicitet
ATE232396T1 (de) Oxydiertes thymosin beta 4
DK486588D0 (da) Konjungater af cytokininer med immunglobuliner
ATE297200T1 (de) Facettenreiches verfahren zur unterdrückung der vermehrung latenter viren in menschen und tieren
DE69826695D1 (de) Arylharnstoffderivate zur behandlung von inflammatorischen oder immunomodulatorischen erkrankungen
ATE320435T1 (de) Oxazolo-, thiazolo- und selenazolo-(4,5- c)naphthyridin-4-amine und analoge davon
DK0981343T3 (da) Probucolmonoestere til behandling af kardiovaskulær og inflammatorisk sygdom
DE59101397D1 (de) O-glycosyliertes ifn-alpha.
ES2154252T1 (es) Inhibicion de la quinasa p38 utilizando difenil-ureas simetricas y asimetricas.
CL2010000828A1 (es) Composicion farmaceutica que comprende un conjugado pegilado de interferon alfa y ribavirina, util en la preparacion de un medicamento para las infecciones de hepatitis c cronica.
DK0726778T3 (da) Oral administration af kemisk modificerede proteiner
NO972391D0 (no) 2-substituerte 1,2,5-tiadiazolidin-3-on 1,1-dioksider og preparater og metoder for anvendelse derav
MX9203319A (es) Metodo para la preparacion de cristales de alfa-2 interferona.
DK1150703T3 (da) Behandling af multipel sclerose med chaperonin 10 og beta-interferon
DE69027472D1 (de) Arylsubstituierte Rhodaninderivate
GEP20002092B (en) 5,6-Dihydropyrone Derivatives Pharma¬ceutical Compositions on the Base of them and Method for Treatment of Antiviral diseases
EP0553294A4 (en) Methods and compositions for the treatment of cell proliferation disorders
NO922456L (no) Bcrf1-proteiner som inhibitorer av interferon-gamma
ATE189262T1 (de) Interferon-alpha/beta bindendes protein, seine herstellung und seine enthaltende pharmazeutische zusammensetzungen
DE69000791D1 (de) Therapeutische mittel fuer metabolische knochenkrankheiten.
DK0440100T3 (da) Anvendelse af et galdesyresalt og et lipid
GR3035004T3 (en) Method and composition for the treatment of herpes related disorders.
DK0907373T3 (da) Anvendelse af synergistiske sammensætninger af IL-12 og IFN-alfa til behandling af infektionssygsomme
ES1015531Y (es) Jeringuilla perfeccionada de unica utilizacion.
ES1026147Y (es) Canula traqueal perfeccionada.